Inflammation and infections in unreported chronic obstructive pulmonary disease exacerbations
Received 25 October 2018
Accepted for publication 22 February 2019
Published 10 April 2019 Volume 2019:14 Pages 823—833
Checked for plagiarism Yes
Review by Single-blind
Peer reviewers approved by Ms Justinn Cochran
Peer reviewer comments 3
Editor who approved publication: Dr Richard Russell
Maria Adelaide Calderazzo,1 Maria-Belen Trujillo-Torralbo,1,2 Lydia Joanne Finney,1 Aran Singanayagam,1 Eteri Bakhsoliani,1 Vijay Padmanaban,2 Tatiana Kebadze,1 Julia Aniscenko,1 Sarah L Elkin,1,2 Sebastian L Johnston,1,2 Patrick Mallia1,2
1National Heart and Lung Institute, Imperial College, London, UK; 2Department of Respiratory Medicine, Imperial College Healthcare NHS Trust, London, UK
Purpose: COPD patients often do not report acute exacerbations to healthcare providers – unreported exacerbations. It is not known whether variances in symptoms, airway obstruction, aetiology and inflammatory responses account for differences in reporting of COPD exacerbations. The aims of the study were to compare symptoms, lung function changes, aetiology and inflammatory markers between exacerbations that were reported to healthcare providers or treated, with those that were unreported and untreated.
Patients and methods: We recruited a cohort of COPD patients and collected clinical data and blood and airway samples when stable and during acute exacerbations. Virological and bacterial analyses were carried out and inflammatory markers measured.
Results: We found no differences in symptoms, lung function, incidence of infection and inflammatory markers between reported and unreported exacerbations. Subjects who reported all exacerbations had higher BODE scores, lower FEV1 and more exacerbations compared with those who did not.
Conclusion: The failure to report exacerbations is not related to the severity, aetiology or inflammatory profile of the exacerbation. Patients with less severe COPD and less frequent exacerbations are less likely to report exacerbations. The decision to report an exacerbation is not an objective marker of exacerbation severity and therefore studies that do not count unreported exacerbations will underestimate the frequency of clinically significant exacerbations. A better understanding of the factors that determine non-reporting of exacerbations is required to improve exacerbation reporting.
Trial registration: ClinicalTrials.gov Identifier: NCT01376830. Registered June 17, 2011
Keywords: chronic obstructive pulmonary disease, acute exacerbations, unreported exacerbations
This work is published by Dove Medical Press Limited, and licensed under a Creative Commons Attribution License. The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/. The license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.Download Article [PDF] View Full Text [HTML][Machine readable]